Janus Henderson Group PLC Catalent, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Catalent, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,094,620 shares of CTLT stock, worth $183 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,094,620
Previous 9,560,698
67.63%
Holding current value
$183 Million
Previous $540 Million
67.76%
% of portfolio
0.1%
Previous 0.3%
Shares
29 transactions
Others Institutions Holding CTLT
# of Institutions
496Shares Held
163MCall Options Held
286KPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$910 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$652 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$435 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$294 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.7B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...